Short Answer Questions. Answer all questions. Time allowed 1 hour
- What is the absorbance of a 1cm pathlength of acetonitrile at 200nm when the percentage transmission is 80%? 10 marks
A = 2-log10%T where A= absorbance
A = 2-log1080 %T= % transmission
A = 0.0969
- Define 1 unit of enzyme activity. 10 marks
The amount of enzyme that catalyses the conversion of one micromole of substrate to product in 1 minute under appropriate conditions
3. List five biochemical abnormalities associated with rhabdomyolysis. 2 marks each
Raised CK Hypocalcaemia
Hyperkalaemia Hyperuricaemia
Hyperphosphataemia Myoglobinuria
Raised Urea/Creatinine (if renal failure) Raised LDH
Abnormal LFT (if liver involvement) Raised AST
Acidosis
- A 70 kg man with severe hypomagnesaemia requires 24 mmol of magnesium intravenously.
a. What volume of solution containing 0.48g/2mL of anhydrous magnesium sulphate would be needed ? (Atomic Weights Mg = 24, S=32) 5 marks
b. What is the final calculated osmolarity of the solution if this volume is added to 500 mL of 0.9% w/v sodium chloride? 5 marks
a. 24 mmol of magnesium are required
The stock solution contains 0.48g/2mL MgSO4
Molecular Weight of MgSO4 = 24 + 32 + (4 x 16) = 120
Therefore molar concentration of stock = 0.48/120 = 0.004 mol/2mL = 2 mmol/mL
Volume containing 24 mmol of Magnesium = 24/ 2 = 12 mL
b. Final volume of solution = 512 mL
500 mL of 0.9% w/v saline contains 4.5g of NaCl = 4.5/(23+35) = 0.0776 mols = 77.6 mmol NaCl
12mL of MgSO4 contains 24 mmol
Therefore 512 mL of solution contains 24 mmol MgSO4 and 77.6 mmol of sodium chloride
Concentration of NaCl/L = (77.6/512)*1000 = 151.56mmol/L
Concentration of MgSO4 = (24/512)*1000 = 46.88 mmol/L
Both compounds dissociate in solution therefore the osmolarity the solution = (2 * 151.560 + (2* 46.88) = 396.9 mmol/L
- A new screening test has been developed to detect a tumour with a prevalence of 1 in 5000 of the population. It has a diagnostic sensitivity of 95% and a specificity of 97%.
- Calculate the diagnostic efficiency of the test 5 marks
- Calculate the negative predictive value of the test 5 marks
Assuming a population of 1 million
|
|
Diseased |
Non-Diseased |
Total |
|
Positive Test |
190 (TP) |
29994 (FP) |
30184 |
|
Negative Test |
10 (FN) |
969806 (TN) |
969816 |
|
|
200 |
999800 |
1000000 |
a. Diagnostic Efficiency = (TP+TN)/(TP+TN+FN+FP) = [(190+969806)/1000000] *100 = 97%
b. Negative Predictive Value = TN/(TN+FN) = [969903/(969903+10)]*100 = 99.999%
6. A 22 year old painter and decorator presented to his GP with a 2 week history of lethargy, malaise, headaches, nausea and cramping abdominal pain. Blood results were as follows
Na 140 mmol/L
K 4.2 mmol/L
U 5.6 mmol/L
Cre 103 umol/L
Alb 40 g/L
ALT 24 U/L
ALP 88 U/L
Bili 6 umol/L
Hb 9.4 g/L
MCV 92 fl
WCC 13.2 x109 L-1
Platelets 231 x109 L-1
Basophilic stippling of erythrocytes was noted on the blood film.
a. What is the most likely diagnosis? 4 marks
b. What is the mechanism behind the abnormal blood results? 3 marks
c. What management/treatment options are available? 3 marks
a. Lead poisoning
b. Low Hb - lead is an electropositive metal with a high affinity for sulphydryl groups and thus inhibits sulphydryl dependent enzymes such as 5-aminolaevulinic acid dehydratase and ferrochetalase which are essential for the synthesis of haem.
Basophilic stippling – due to inhibition of pyrimidine 5’-nucleotidase
c. Removal of patient from source of exposure
Use of chelating agents if blood lead sufficiently high to warrant (e.g. sodium calcium edentate, 2,3- dimercaptosuccinic acid) to form complexes with lead preventing its binding to cell constituents and allowing it to be eliminated in urine
- A paper describing the use of a new tumour marker included the following data relating to the concentrations of histologically proven disease:-
Number of diseased patients (n) = 110
Mean concentration of tumour marker = 80 U/L
Standard error of mean = 5.5
a. Calculate the standard deviation of the mean 5 marks
b. If the reference interval for the tumour marker in non-diseased subjects is 10-15 U/L what can you conclude about the distribution of data in the diseased patients in this study? 5 marks
a. SE = SD/square route of n
SD = 5.5 * square route 110 = 57.7
b. The data are not normally distributed as mean plus or minus 2SDs gives a negative value for the marker. If normal subjects have concentrations 10-15 U/L then negative values won’t occur
- One serum and one urine sample collected from a patient for the measurement of creatinine clearance were each assayed 10 times with the following results:-
Urine Creatinine Serum Creatinine
mmol/L umol/L
11.1 102
11.5 108
11.9 107
10.9 112
12.1 103
11.2 105
11.8 109
11.7 114
11.6 110
12.1 100
The urine was a 24 hour collection and had a volume of 1250 mL.
What is the analytical imprecision in the creatinine clearance determination?
10 marks
Approach 1
%CV = (SD/mean) *100
SD = sq route of Σ(x-x)2/n-1 where x = individual value
x = mean
However should be able to work out standard deviation on scientific calculator – suggest familiarise yourself with how to do this since it will save time
CV overall = square route of (CVserum2 + CVurine2)
Urine Creatinine Serum Creatinine
mmol/L umol/L
Mean 11.59 107
SD 0.415 4.50
%CV 3.58 4.2
CV overall = square route of (4.22 + 3.582) = 5.52%
Approach 2
Calculate the variable part of the creatinine clearance for each point
Creatinine clearance = UV/ST = constant * (V/S)
where U = urine creatinine
S = serum creatinine
V = volume
T = time
|
Urine creat mmol/L |
Serum creat umol/L |
Urine creat/Serum creat mmol/umol |
|
11.1 |
102 |
0.109 |
|
11.5 |
108 |
0.106 |
|
11.9 |
107 |
0.111 |
|
10.9 |
112 |
0.097 |
|
12.1 |
103 |
0.117 |
|
11.2 |
105 |
0.107 |
|
11.8 |
109 |
0.108 |
|
11.7 |
114 |
0.103 |
|
11.6 |
110 |
0.105 |
|
12.1 |
100 |
0.121 |
|
|
mean |
0.108 |
|
|
SD |
0.0068 |
|
|
%CV |
6.3 |
9. Match the following disease states with their biochemical/other characteristics in adults
a. Carcinoid disease
b. Phaeochromocytoma
c. Gastrinoma
d. VIPoma
e. Somatostatinoma
Biochemical/Other Characteristics
B1. Fasting blood sugar of greater than 9.0mmol/L on 2 occasions, raised faecal fats
B2 Pancreatic tumour with achlorhydria
B3 Pancreatic tumour often associated with MEN1
B4 Elevated urine 3-hydroxy 4-methoxy mandelic acid output
B5 Elevated urine urine 5 –hydroxyindol acetic acid output and raised plasma chromogranin A
B6 Raised plasma glucagons 2 marks each
a. B5
b. B4
c. B3
d. B2
e. B1
- A 54 year old man with chronic renal failure is admitted to AE with chest pain. ECG changes are suggestive of a possible MI but are not conclusive. Troponin T at 12 hours post onset of chest pain= 0.12 ug/L. The renal registrar phones wanting to know if the patient has had an MI.
a. What do you tell him?
b. What further investigations may help? 5 marks each
- TnT = 0.12 ug/L in the context of ischaemic chest pain would be consistent with MI. However, raised TnT have been reported in CRF in the absence of MI.
- Definition of MI requires demonstration of change in TnT concentration so repeat TnT may help as may CK or CKMB.
This post is tagged
West Midlands Training Course/MSc in Clinical Biochemistry
No Comments
Leave a Reply